MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating <i>SOCS1</i>, <i>SOCS6</i>, and <i>PTEN</i>Xinying Xue, Sanhong Liu|Oncotarget|2016Cited by 182
Plasmid-mediated quinolone resistance – current knowledge and future perspectivesXizhou Guan, Lei Pan, Kaifei Wang et al.|Journal of International Medical Research|2013Cited by 70
Early tumor volume change as a novel CT RECIST indicator for predicting pathological response and prognosis in NSCLC patients undergoing immunotherapyFan Xu, Mei Xie, Jie Gao et al.|Biomedical Signal Processing and Control|2025Cited by 0